WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 14 fonti

Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.

Raccontata dabiopharmadive.comapnews.comstatnews.comindependent.co.ukendpoints.newseconomictimes.indiatimes.commorningstar.comcnn.comoglobo.globo.commedpagetoday.compbs.orgsciencealert.com+2 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
gizmodo.comStai leggendo6 h fa

Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.

originale

Timeline cronologica

  1. giovedì 28 maggio 2026·biopharmadive.com

    GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

    The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.

  2. giovedì 28 maggio 2026·apnews.com

    Experimental hepatitis B drug may offer 'functional cure' for some patients

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.

economictimes.indiatimes.com
1 g fa

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of treatment. This offers a potential…

Leggi questa versione → originale
independent.co.uk1 g fa

FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

Leggi questa versione → originale
pbs.org1 g fa

Hepatitis B drug may offer 'functional cure' for some patients

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in…

Leggi questa versione → originale
medpagetoday.com1 g fa

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings 'will change the landscape' of treatment, researcher says

Leggi questa versione → originale
apnews.com1 g fa

Experimental hepatitis B drug may offer 'functional cure' for some patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.

Leggi questa versione → originale
  • giovedì 28 maggio 2026·statnews.com

    Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

    An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.

  • giovedì 28 maggio 2026·independent.co.uk

    Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

  • giovedì 28 maggio 2026·endpoints.news

    GSK's functional cure data for hepatitis B drug are a major leap over standard of care

    GSK has shared detailed results from a pair of late-stage trials testing a chronic hepatitis B treatment originally developed by Ionis Pharmaceuticals, with regulatory reviews…

  • giovedì 28 maggio 2026·economictimes.indiatimes.com

    GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

    GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of…

  • giovedì 28 maggio 2026·morningstar.com

    Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic…

    Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

  • giovedì 28 maggio 2026·independent.co.uk

    FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

  • giovedì 28 maggio 2026·cnn.com

    Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN

    A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers…

  • giovedì 28 maggio 2026·oglobo.globo.com

    Nova injeção elimina completamente hepatite B em 20% dos pacientes

    Tratamentos atuais proporcionam cura para apenas cerca de 1% das pessoas que vivem com o vírus de forma crônica

  • giovedì 28 maggio 2026·medpagetoday.com

    Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

    Findings 'will change the landscape' of treatment, researcher says

  • giovedì 28 maggio 2026·pbs.org

    Hepatitis B drug may offer 'functional cure' for some patients

    Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that…

  • venerdì 29 maggio 2026·sciencealert.com

    New Drug Offers 'Functional Cure' For Dangerous Liver Virus

    WASHINGTON (AP) – A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional…

  • venerdì 29 maggio 2026·lanacion.com.ar

    Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin medicación

    La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20%…

  • venerdì 29 maggio 2026·gizmodo.com

    Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

    Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.